An Introduction and Overview of RON Receptor Tyrosine Kinase Signaling
Abstract
:1. Genetic Overview of RON
2. Structural Overview of RON
3. RON Structural Variants
4. Non-Canonical RON Signaling Mechanisms
5. RON Signaling in Macrophages and Other Bone Marrow-Derived Cells
6. RON Signaling in Reproduction and Development
7. RON Signaling and Inflammation
8. RON Signaling in Wound Healing
9. RON Signaling in Ciliary Movement
10. RON in Prostate Cancer
11. RON in Breast Cancer
12. Emerging Ligand Crosstalk
13. Open Questions in the Field of RON Signaling
14. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Kent, W.J.; Sugnet, C.W.; Furey, T.S.; Roskin, K.M.; Pringle, T.H.; Zahler, A.M.; Haussler, D. The Human Genome Browser at UCSC. Genome Res. 2002, 12, 996–1006. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Yao, H.-P.; Zhou, Y.-Q.; Zhang, R.; Wang, M.-H. MSP–RON signalling in cancer: Pathogenesis and therapeutic potential. Nat. Rev. Cancer 2013, 13, 466–481. [Google Scholar] [CrossRef] [PubMed]
- Hunt, B.G.; Jones, A.; Lester, C.; Davis, J.C.; Benight, N.M.; Waltz, S.E. RON (MST1R) and HGFL (MST1) Co-Overexpression Supports Breast Tumorigenesis through Autocrine and Paracrine Cellular Crosstalk. Cancers 2022, 14, 2493. [Google Scholar] [CrossRef] [PubMed]
- Dai, W.; Zheng, H.; Cheung, A.K.L.; Tang, C.S.-M.; Ko, J.M.Y.; Wong, B.W.Y.; Leong, M.M.L.; Sham, P.C.; Cheung, F.; Kwong, D.L.-W.; et al. Whole-exome sequencing identifies <i>MST1R</i> as a genetic susceptibility gene in nasopharyngeal carcinoma. Proc. Natl. Acad. Sci. USA 2016, 113, 3317–3322. [Google Scholar]
- UCSC Genome Browser. Available online: http://genome.ucsc.edu (accessed on 1 August 2022).
- Chao, K.L.; Tsai, I.-W.; Chen, C.; Herzberg, O. Crystal Structure of the Sema-PSI Extracellular Domain of Human RON Receptor Tyrosine Kinase. PLoS ONE 2012, 7, e41912. [Google Scholar] [CrossRef]
- Brown, N.E.; Sullivan, C.; Waltz, S.E. Therapeutic Considerations for Ron Receptor Expression in Prostate Cancer. EMS Cancer Sci. J. 2018, 1, 3. [Google Scholar]
- Wang, M.-H.; Julian, F.M.; Breathnach, R.; Godowski, P.J.; Takehara, T.; Yoshikawa, W.; Hagiya, M.; Leonard, E.J. Macrophage Stimulating Protein (MSP) Binds to Its Receptor via the MSP β Chain. J. Biol. Chem. 1997, 272, 16999–17004. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wang, M.-H.; Zhou, Y.-Q.; Chen, Y.-Q. Macrophage-Stimulating Protein and RON Receptor Tyrosine Kinase: Potential Regulators of Macrophage Inflammatory Activities. Scand. J. Immunol. 2002, 56, 545–553. [Google Scholar] [CrossRef]
- Wang, X.; Yennawar, N.; Hankey, P.A. Autoinhibition of the Ron receptor tyrosine kinase by the juxtamembrane domain. Cell Commun. Signal. 2014, 12, 28. [Google Scholar] [CrossRef] [Green Version]
- Gaudino, G.; Follenzi, A.; Naldini, L.; Collesi, C.; Santoro, M.M.; Gallo, K.; Godowski, P.; Comoglio, P. RON is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSP. EMBO J. 1994, 13, 3524–3532. [Google Scholar] [CrossRef]
- Iwama, A.; Yamaguchi, N.; Suda, T. STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family. EMBO J. 1996, 15, 5866–5875. [Google Scholar] [CrossRef] [PubMed]
- Danilkovitch, A.; Donley, S.; Skeel, A.; Leonard, E.J. Two Independent Signaling Pathways Mediate the Antiapoptotic Action of Macrophage-Stimulating Protein on Epithelial Cells. Mol. Cell. Biol. 2000, 20, 2218–2227. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Santoro, M.M.; Collesi, C.; Grisendi, S.; Gaudino, G.; Comoglio, P.M. Constitutive activation of the RON gene promotes invasive growth but not transformation. Mol. Cell. Biol. 1996, 16, 7072–7083. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bardella, C.; Costa, B.; Maggiora, P.; Patane’, S.; Olivero, M.; Ranzani, G.N.; De Bortoli, M.; Comoglio, P.M.; Di Renzo, M.F. Truncated RON Tyrosine Kinase Drives Tumor Cell Progression and Abrogates Cell-Cell Adhesion Through E-Cadherin Transcriptional Repression. Cancer Res. 2004, 64, 5154–5161. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chakedis, J.; French, R.; Babicky, M.L.; Jaquish, D.; Howard, H.; Mose, E.; Lam, R.; Holman, P.; Miyamoto, J.; Walterscheid, Z.; et al. A novel protein isoform of the RON tyrosine kinase receptor transforms human pancreatic duct epithelial cells. Oncogene 2016, 35, 3249–3259. [Google Scholar] [CrossRef] [Green Version]
- Chakedis, J.; French, R.; Babicky, M.; Jaquish, D.; Mose, E.; Cheng, P.; Holman, P.; Howard, H.; Miyamoto, J.; Porras, P.; et al. Characterization of RON protein isoforms in pancreatic cancer: Implications for biology and therapeutics. Oncotarget 2016, 7, 45959–45975. [Google Scholar] [CrossRef]
- Ma, Q.; Zhang, K.; Guin, S.; Zhou, Y.-Q.; Wang, M.-H. Deletion or insertion in the first immunoglobulin-plexin-transcription (IPT) domain differentially regulates expression and tumorigenic activities of RON receptor Tyrosine Kinase. Mol. Cancer 2010, 9, 307. [Google Scholar] [CrossRef] [Green Version]
- Krishnaswamy, S.; Mohammed, A.K.; Tripathi, G.; Alokail, M.S.; Al-Daghri, N.M. Splice variants of the extracellular region of RON receptor tyrosine kinase in lung cancer cell lines identified by PCR and sequencing. BMC Cancer 2017, 17, 738. [Google Scholar] [CrossRef] [Green Version]
- Liu, X.; Zhao, L.; Derose, Y.S.; Lin, Y.-C.; Bieniasz, M.; Eyob, H.; Buys, S.S.; Neumayer, L.; Welm, A.L. Short-Form Ron Promotes Spontaneous Breast Cancer Metastasis through Interaction with Phosphoinositide 3-Kinase. Genes Cancer 2011, 2, 753–762. [Google Scholar] [CrossRef] [Green Version]
- Wang, Z.; Yang, Y.; Hu, S.; He, J.; Wu, Z.; Qi, Z.; Huang, M.; Liu, R.; Lin, Y.; Tan, C.; et al. Short-form RON (sf-RON) enhances glucose metabolism to promote cell proliferation via activating β-catenin/SIX1 signaling pathway in gastric cancer. Cell Biol. Toxicol. 2021, 37, 35–49. [Google Scholar] [CrossRef]
- Persons, D.A.; Paulson, R.F.; Loyd, M.R.; Herley, M.T.; Bodner, S.M.; Bernstein, A.; Correll, P.H.; Ney, P.A. Fv2 encodes a truncated form of the Stk receptor tyrosine kinase. Nat. Genet. 1999, 23, 159–165. [Google Scholar] [CrossRef] [PubMed]
- Wetzel, C.C.; Leonis, M.A.; Dent, A.; Olson, M.A.; Longmeier, A.M.; Ney, P.A.; Boivin, G.P.; Kader, S.A.; Caldwell, C.C.; Degen, S.J.; et al. Short-form Ron receptor is required for normal IFN-γ production in concanavalin A-induced acute liver injury. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 292, G253–G261. [Google Scholar] [CrossRef] [PubMed]
- Lai, S.-C.A.; Gundlapalli, H.; Ekiz, H.A.; Jiang, A.; Fernandez, E.; Welm, A.L. Blocking Short-Form Ron Eliminates Breast Cancer Metastases through Accumulation of Stem-Like CD4+ T Cells That Subvert Immunosuppression. Cancer Discov. 2021, 11, 3178–3197. [Google Scholar] [CrossRef] [PubMed]
- Wu, Z.; Zhang, Z.; Ge, X.; Lin, Y.; Dai, C.; Chang, J.; Liu, X.; Geng, R.; Wang, C.; Chen, H.; et al. Identification of short-form RON as a novel intrinsic resistance mechanism for anti-MET therapy in MET-positive gastric cancer. Oncotarget 2015, 6, 40519–40534. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ekiz, H.A.; Lai, S.-C.A.; Gundlapalli, H.; Haroun, F.; Williams, M.A.; Welm, A.L. Inhibition of RON kinase potentiates anti-CTLA-4 immunotherapy to shrink breast tumors and prevent metastatic outgrowth. Oncoimmunology 2018, 7, e1480286. [Google Scholar] [CrossRef]
- Benight, N.M.; E Waltz, S. Ron receptor tyrosine kinase signaling as a therapeutic target. Expert Opin. Ther. Targets 2012, 16, 921–931. [Google Scholar] [CrossRef] [Green Version]
- E Peace, B.; Hill, K.J.; Degen, S.J.; E Waltz, S. Cross-talk between the receptor tyrosine kinases Ron and epidermal growth factor receptor. Exp. Cell Res. 2003, 289, 317–325. [Google Scholar] [CrossRef]
- Jaquish, D.V.; Yu, P.T.; Shields, D.J.; French, R.P.; Maruyama, K.P.; Niessen, S.; Hoover, H.; A Cheresh, D.; Cravatt, B.; Lowy, A.M. IGF1-R signals through the RON receptor to mediate pancreatic cancer cell migration. Carcinogenesis 2011, 32, 1151–1156. [Google Scholar] [CrossRef] [Green Version]
- Eckerich, C.; Schulte, A.; Martens, T.; Zapf, S.; Westphal, M.; Lamszus, K. RON receptor tyrosine kinase in human gliomas: Expression, function, and identification of a novel soluble splice variant. J. Neurochem. 2009, 109, 969–980. [Google Scholar] [CrossRef]
- Keller, J.; Nimnual, A.S.; Shroyer, K.R.; Joy, C.; Ischenko, I.; Chandler, C.S.; Dong, L.M.; Hayman, M.J.; Chan, E.L. Ron tyrosine kinase receptor synergises with EGFR to confer adverse features in head and neck squamous cell carcinoma. Br. J. Cancer 2013, 109, 482–492. [Google Scholar] [CrossRef]
- Liu, H.-S.; Hsu, P.-Y.; Lai, M.-D.; Chang, H.-Y.; Ho, C.-L.; Cheng, H.-L.; Chen, H.-T.; Lin, Y.-J.; Wu, T.-J.; Tzai, T.-S.; et al. An unusual function of RON receptor tyrosine kinase as a transcriptional regulator in cooperation with EGFR in human cancer cells. Carcinogenesis 2010, 31, 1456–1464. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Batth, I.; Yun, H.; Hussain, S.; Meng, P.; Osmulski, P.; Huang, T.H.-M.; Bedolla, R.; Profit, A.; Reddick, R.; Kumar, A. Crosstalk between RON and androgen receptor signaling in the development of castration resistant prostate cancer. Oncotarget 2016, 7, 14048–14063. [Google Scholar] [CrossRef] [PubMed]
- Chang, H.-Y.; Liu, H.-S.; Lai, M.-D.; Tsai, Y.-S.; Tzai, T.-S.; Cheng, H.-L.; Chow, N.-H. Hypoxia Promotes Nuclear Translocation and Transcriptional Function in the Oncogenic Tyrosine Kinase RON. Cancer Res 2014, 74, 4549–4562. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Carpenter, G.; Liao, H.-J. Receptor Tyrosine Kinases in the Nucleus. Cold Spring Harb. Perspect. Biol. 2013, 5, a008979. [Google Scholar] [CrossRef] [Green Version]
- Song, S.; Rosen, K.M.; Corfas, G. Biological Function of Nuclear Receptor Tyrosine Kinase Action. Cold Spring Harb. Perspect. Biol. 2013, 5, a009001. [Google Scholar] [CrossRef] [Green Version]
- Iwama, A.; Wang, M.; Yamaguchi, N.; Ohno, N.; Okano, K.; Sudo, T.; Takeya, M.; Gervais, F.; Morissette, C.; Leonard, E. Terminal differentiation of murine resident peritoneal macrophages is characterized by expression of the STK protein tyrosine kinase, a receptor for macrophage-stimulating protein. Blood 1995, 86, 3394–3403. [Google Scholar] [CrossRef] [Green Version]
- Banu, N.; Price, D.J.; London, R.; Deng, B.; Mark, M.; Godowski, P.J.; Avraham, H. Modulation of megakaryocytopoiesis by human macrophage-stimulating protein, the ligand for the RON receptor. J. Immunol. 1996, 156, 2933–2940. [Google Scholar] [CrossRef]
- Anam, K.; Davis, T.A. Comparative analysis of gene transcripts for cell signaling receptors in bone marrow-derived hematopoietic stem/progenitor cell and mesenchymal stromal cell populations. Stem Cell Res. Ther. 2013, 4, 112. [Google Scholar] [CrossRef] [Green Version]
- Chen, Y.Q.; Fisher, J.H.; Wang, M.H. Activation of the RON receptor tyrosine kinase inhibits inducible nitric oxide synthase (iNOS) expression by murine peritoneal exudate macrophages: Phosphatidylinositol-3 kinase is required for RON-mediated inhibition of iNOS expression. J. Immunol. 1998, 161, 4950–4959. [Google Scholar] [CrossRef]
- Morrison, A.C.; Wilson, C.B.; Ray, M.; Correll, P.H. Macrophage-Stimulating Protein, the Ligand for the Stem Cell-Derived Tyrosine Kinase/RON Receptor Tyrosine Kinase, Inhibits IL-12 Production by Primary Peritoneal Macrophages Stimulated with IFN-γ and Lipopolysaccharide. J. Immunol. 2004, 172, 1825–1832. [Google Scholar] [CrossRef] [Green Version]
- Liu, Q.P.; Fruit, K.; Ward, J.; Correll, P.H. Negative regulation of macrophage activation in response to IFN-gamma and lipopolysaccharide by the STK/RON receptor tyrosine kinase. J. Immunol. 1999, 163, 6606–6613. [Google Scholar] [CrossRef] [PubMed]
- Chen, Y.-Q.; Zhou, Y.-Q.; Wang, M.-H. Activation of the RON receptor tyrosine kinase protects murine macrophages from apoptotic death induced by bacterial lipopolysaccharide. J. Leukoc. Biol. 2002, 71, 359–366. [Google Scholar] [CrossRef] [PubMed]
- Morrison, A.C.; Correll, P.H. Activation of the Stem Cell-Derived Tyrosine Kinase/RON Receptor Tyrosine Kinase by Macrophage-Stimulating Protein Results in the Induction of Arginase Activity in Murine Peritoneal Macrophages. J. Immunol. 2002, 168, 853–860. [Google Scholar] [CrossRef] [Green Version]
- Correll, P.; Iwama, A.; Tondat, S.; Mayrhofer, G.; Suda, T.; Bernstein, A. Deregulated inflammatory response in mice lacking the STK/RON receptor tyrosine kinase. Genes Funct. 1997, 1, 69–83. [Google Scholar] [CrossRef] [PubMed]
- Zhou, Y.-Q.; Chen, Y.-Q.; Fisher, J.H.; Wang, M.-H. Activation of the RON Receptor Tyrosine Kinase by Macrophage-stimulating Protein Inhibits Inducible Cyclooxygenase-2 Expression in Murine Macrophages. J. Biol. Chem. 2002, 277, 38104–38110. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lee, E.S.; Kalantari, P.; Tsutsui, S.; Klatt, A.; Holden, J.; Correll, P.H.; Power, C.; Henderson, A.J. RON Receptor Tyrosine Kinase, a Negative Regulator of Inflammation, Inhibits HIV-1 Transcription in Monocytes/Macrophages and Is Decreased in Brain Tissue from Patients with AIDS. J. Immunol. 2004, 173, 6864–6872. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wang, M.-H.; Fung, H.-L.; Chen, Y.-Q. Regulation of the RON Receptor Tyrosine Kinase Expression in Macrophages: Blocking the RON Gene Transcription by Endotoxin-Induced Nitric Oxide. J. Immunol. 2000, 164, 3815–3821. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ray, M.; Yu, S.; Sharda, D.R.; Wilson, C.B.; Liu, Q.; Kaushal, N.; Prabhu, K.S.; Hankey, P.A. Inhibition of TLR4-Induced IκB Kinase Activity by the RON Receptor Tyrosine Kinase and Its Ligand, Macrophage-Stimulating Protein. J. Immunol. 2010, 185, 7309–7316. [Google Scholar] [CrossRef] [Green Version]
- Wilson, C.B.; Ray, M.; Lutz, M.; Sharda, D.; Xu, J.; Hankey, P.A. The RON receptor tyrosine kinase regulates IFN-gamma production and responses in innate immunity. J. Immunol. 2008, 181, 2303–2310. [Google Scholar] [CrossRef] [Green Version]
- Gardner, C.R.; Hankey, P.; Mishin, V.; Francis, M.; Yu, S.; Laskin, J.D.; Laskin, D.L. Regulation of alternative macrophage activation in the liver following acetaminophen intoxication by stem cell-derived tyrosine kinase. Toxicol. Appl. Pharmacol. 2012, 262, 139–148. [Google Scholar] [CrossRef] [Green Version]
- Kulkarni, R.M.; Stuart, W.D.; E Waltz, S. Ron receptor-dependent gene regulation of Kupffer cells during endotoxemia. Hepatobiliary Pancreat. Dis. Int. 2014, 13, 281–292. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nikolaidis, N.M.; Gray, J.K.; Gurusamy, D.; Fox, W.; Stuart, W.D.; Huber, N.; Waltz, S.E. Ron receptor tyrosine kinase negatively regulates TNFα production in alveolar macrophages by inhibiting NF-κB activity and ADAM17 production. Shock 2010, 33, 197. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chaudhuri, A.; Wilson, N.S.; Yang, B.; Martinez, A.P.; Liu, J.; Zhu, C.; Bricker, N.; Couto, S.; Modrusan, Z.; French, D.; et al. Host genetic background impacts modulation of the TLR4 pathway by RON in tissue-associated macrophages. Immunol. Cell Biol. 2013, 91, 451–460. [Google Scholar] [CrossRef]
- Quantin, B.; Schuhbaur, B.; Gesnel, M.-C.; Dollé, P.; Breathnach, R. Restricted expression of the ron gene encoding the macrophage stimulating protein receptor during mouse development. Dev. Dyn. 1995, 204, 383–390. [Google Scholar] [CrossRef]
- Hess, K.A.; Waltz, S.; Chan, E.L.; Degen, S.J. Receptor Tyrosine Kinase Ron Is Expressed in Mouse Reproductive Tissues During Embryo Implantation and Is Important in Trophoblast Cell Function1. Biol. Reprod. 2003, 68, 1267–1275. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Muraoka, R.S.; Sun, W.Y.; Colbert, M.C.; Waltz, S.E.; Witte, D.P.; Degen, J.L.; Degen, S.J.F. The Ron/STK receptor tyrosine kinase is essential for peri-implantation development in the mouse. J. Clin. Investig. 1999, 103, 1277–1285. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Waltz, S.E.; Eaton, L.; Toney-Earley, K.; Hess, K.A.; Peace, B.E.; Ihlendorf, J.R.; Wang, M.H.; Kaestner, K.H.; Degen, S.J. Ron-mediated cytoplasmic signaling is dispensable for viability but is required to limit inflammatory responses. J. Clin. Investig. 2001, 108, 567–576. [Google Scholar] [CrossRef]
- Hess, K.A.; Waltz, S.E.; Toney-Earley, K.; Degen, S.J. The receptor tyrosine kinase Ron is expressed in the mouse ovary and regulates inducible nitric oxide synthase levels and ovulation. Fertil. Steril. 2003, 80 (Suppl. S2), 747–754. [Google Scholar] [CrossRef]
- Ohshiro, K.; Iwama, A.; Matsuno, K.; Ezaki, T.; Sakamoto, O.; Hamaguchi, I.; Takasu, N.; Suda, T. Molecular Cloning of Rat Macrophage-Stimulating Protein and Its Involvement in the Male Reproductive System. Biochem. Biophys. Res. Commun. 1996, 227, 273–280. [Google Scholar] [CrossRef]
- Gurusamy, D.; Ruiz-Torres, S.J.; Johnson, A.L.; Smith, D.A.; Waltz, S.E. Hepatocyte growth factor-like protein is a positive regulator of early mammary gland ductal morphogenesis. Mech. Dev. 2014, 133, 11–22. [Google Scholar] [CrossRef]
- Matsuzaki, S.; Canis, M.; Pouly, J.; Dechelotte, P.; Okamura, K.; Mage, G. The macrophage stimulating protein/RON system: A potential novel target for prevention and treatment of endometriosis. Mol. Hum. Reprod. 2005, 11, 345–349. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kulkarni, R.M.; Stuart, W.D.; Gurusamy, D.; Waltz, S.E. Ron receptor signaling is protective against DSS-induced colitis in mice. Am. J. Physiol. -Gastrointest. Liver Physiol. 2014, 306, G1065–G1074. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mao, T.; Li, J.; Liu, L.; Zhao, W.; Liu, Y.; Gao, K.; Guo, Y.; Xie, T.; Li, N.; Shi, R. Qingchang Wenzhong Decoction Attenuates DSS-Induced Colitis in Rats by Reducing Inflammation and Improving Intestinal Barrier Function via Upregulating the MSP/RON Signalling Pathway. Evidence-Based Complement. Altern. Med. 2017, 2017, 4846876. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Goyette, P.; Lefebvre, C.; Ng, A.; Brant, S.R.; Cho, J.H.; Duerr, R.H.; Silverberg, M.S.; Taylor, K.D.; Latiano, A.; Aumais, G.; et al. Gene-centric association mapping of chromosome 3p implicates MST1 in IBD pathogenesis. Mucosal Immunol. 2008, 1, 131–138. [Google Scholar] [CrossRef] [Green Version]
- Gorlatova, N.; Chao, K.; Pal, L.R.; Araj, R.H.; Galkin, A.; Turko, I.; Moult, J.; Herzberg, O. Protein characterization of a candidate mechanism SNP for Crohn’s disease: The macrophage stimulating protein R689C substitution. PLoS ONE 2011, 6, e27269. [Google Scholar] [CrossRef]
- Kauder, S.E.; Santell, L.; Mai, E.; Wright, L.Y.; Luis, E.; N’Diaye, E.N.; Lutman, J.; Ratti, N.; Sa, S.M.; Maun, H.R.; et al. Functional Consequences of the Macrophage Stimulating Protein 689C Inflammatory Bowel Disease Risk Allele. PLoS ONE 2013, 8, e83958. [Google Scholar] [CrossRef] [Green Version]
- Witte, M.; Huitema, L.F.; Nieuwenhuis, E.E.; Brugman, S. Deficiency in Macrophage-Stimulating Protein Results in Spontaneous Intestinal Inflammation and Increased Susceptibility Toward Epithelial Damage in Zebrafish. Zebrafish 2014, 11, 542–550. [Google Scholar] [CrossRef]
- Kulkarni, R.M.; Kutcher, L.W.; Stuart, W.D.; Carson, D.J.; Leonis, M.A.; Waltz, S.E. Ron receptor-dependent gene regulation in a mouse model of endotoxin-induced acute liver failure. Hepatobiliary Pancreat. Dis. Int. 2012, 11, 383–392. [Google Scholar] [CrossRef]
- Mallakin, A.; Kutcher, L.W.; McDowell, S.A.; Kong, S.; Schuster, R.; Lentsch, A.B.; Aronow, B.J.; Leikauf, G.D.; Waltz, S.E. Gene Expression Profiles of Mst1r-Deficient Mice during Nickel-Induced Acute Lung Injury. Am. J. Respir. Cell Mol. Biol. 2006, 34, 15–27. [Google Scholar] [CrossRef] [Green Version]
- McDowell, S.A.; Mallakin, A.; Bachurski, C.J.; Toney-Earley, K.; Prows, D.R.; Bruno, T.; Kaestner, K.H.; Witte, D.P.; Melin-Aldana, H.; Degen, S.J.F.; et al. The Role of the Receptor Tyrosine Kinase Ron in Nickel-Induced Acute Lung Injury. Am. J. Respir. Cell Mol. Biol. 2002, 26, 99–104. [Google Scholar] [CrossRef]
- Lentsch, A.B.; Pathrose, P.; Kader, S.; Kuboki, S.; Collins, M.H.; Waltz, S.E. The Ron receptor tyrosine kinase regulates acute lung injury and suppresses nuclear factor kappaB activation. Shock 2007, 27, 274–280. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Göblös, A.; Varga, E.; Farkas, K.; Árvai, K.; Kemény, L. Genetic Investigation of Inverse Psoriasis. Life 2021, 11, 654. [Google Scholar] [CrossRef] [PubMed]
- Wang, M.-H.; Dlugosz, A.A.; Sun, Y.; Suda, T.; Skeel, A.; Leonard, E.J. Macrophage-Stimulating Protein Induces Proliferation and Migration of Murine Keratinocytes. Exp. Cell Res. 1996, 226, 39–46. [Google Scholar] [CrossRef]
- Zhao, J.; Hu, L.; Gong, N.; Tang, Q.; Du, L.; Chen, L. The effects of macrophage-stimulating protein on the migration, proliferation, and collagen synthesis of skin fibroblasts in vitro and in vivo. Tissue Eng. Part A 2015, 21, 982–991. [Google Scholar] [CrossRef]
- Glasbey, J.C.; Sanders, A.J.; Bosanquet, D.C.; Ruge, F.; Harding, K.G.; Jiang, W.G. Expression of Hepatocyte Growth Factor-Like Protein in Human Wound Tissue and Its Biological Functionality in Human Keratinocytes. Biomedicines 2015, 3, 110–123. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wang, M.H.; Montero-Julian, F.A.; Dauny, I.; Leonard, E.J. Requirement of phosphatidylinositol-3 kinase for epithelial cell migration activated by human macrophage stimulating protein. Oncogene 1996, 13, 2167–2175. [Google Scholar]
- Santoro, M.M.; Gaudino, G.; Marchisio, P.C. The MSP receptor regulates alpha6beta4 and alpha3beta1 integrins via 14-3-3 proteins in keratinocyte migration. Dev. Cell 2003, 5, 257–271. [Google Scholar] [CrossRef] [Green Version]
- Nanney, L.B.; Skeel, A.; Luan, J.; Polis, S.; Richmond, A.; Wang, M.-H.; Leonard, E.J. Proteolytic Cleavage and Activation of pro-Macrophage-Stimulating Protein and Upregulation of its Receptor in Tissue Injury. J. Investig. Dermatol. 1998, 111, 573–581. [Google Scholar] [CrossRef] [Green Version]
- Danilkovitch, A.; Skeel, A.; Leonard, E.J. Macrophage Stimulating Protein-Induced Epithelial Cell Adhesion Is Mediated by a PI3-K-Dependent, but FAK-Independent Mechanism. Exp. Cell Res. 1999, 248, 575–582. [Google Scholar] [CrossRef]
- Rampino, T.; Collesi, C.; Gregorini, M.; Maggio, M.; Soccio, G.; Guallini, P.; Canton, A.D. Macrophage-Stimulating Protein Is Produced by Tubular Cells and Activates Mesangial Cells. J. Am. Soc. Nephrol. 2002, 13, 649–657. [Google Scholar] [CrossRef]
- Rampino, T.; Soccio, G.; Gregorini, M.; Guidetti, C.; Marasà, M.; Maggio, M.; Panichi, V.; Migliori, M.; Libetta, C.; Canton, A.D. Neutralization of Macrophage-Stimulating Protein Ameliorates Renal Injury in Anti–Thy 1 Glomerulonephritis. J. Am. Soc. Nephrol. 2007, 18, 1486–1496. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kobayashi, T.; Furukawa, Y.; Kikuchi, J.; Ito, C.; Miyata, Y.; Muto, S.; Tanaka, A.; Kusano, E. Transactivation of RON receptor tyrosine kinase by interaction with PDGF receptor β during steady-state growth of human mesangial cells. Kidney Int. 2009, 75, 1173–1183. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lee, K.E.; Kim, E.Y.; Kim, C.S.; Choi, J.S.; Bae, E.H.; Ma, S.K.; Kim, K.K.; Lee, J.U.; Kim, S.W. Macrophage-stimulating protein attenuates gentamicin-induced inflammation and apoptosis in human renal proximal tubular epithelial cells. Biochem. Biophys. Res. Commun. 2013, 434, 527–533. [Google Scholar] [CrossRef] [PubMed]
- Lee, K.E.; Kim, E.Y.; Kim, C.S.; Choi, J.S.; Bae, E.H.; Ma, S.K.; Park, J.S.; Jung, Y.D.; Kim, S.H.; Lee, J.U.; et al. Macrophage-stimulating protein attenuates hydrogen peroxide-induced apoptosis in human renal HK-2 cells. Eur. J. Pharmacol. 2013, 715, 304–311. [Google Scholar] [CrossRef] [PubMed]
- Cantaluppi, V.; Biancone, L.; Romanazzi, G.M.; Figliolini, F.; Beltramo, S.; Galimi, F.; Camboni, M.G.; Deriu, E.; Conaldi, P.; Bottelli, A.; et al. Macrophage stimulating protein may promote tubular regeneration after acute injury. J. Am. Soc Nephrol. 2008, 19, 1904–1918. [Google Scholar] [CrossRef] [Green Version]
- Gregorini, M.; Bosio, F.; Rocca, C.; Corradetti, V.; Valsania, T.; Pattonieri, E.F.; Esposito, P.; Bedino, G.; Collesi, C.; Libetta, C.; et al. Mesenchymal stromal cells reset the scatter factor system and cytokine network in experimental kidney transplantation. BMC Immunol. 2014, 15, 44. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sakamoto, O.; Iwama, A.; Amitani, R.; Takehara, T.; Yamaguchi, N.; Yamamoto, T.; Masuyama, K.; Yamanaka, T.; Ando, M.; Suda, T. Role of macrophage-stimulating protein and its receptor, RON tyrosine kinase, in ciliary motility. J. Clin. Investig. 1997, 99, 701–709. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Manzanares, D.; Monzon, M.-E.; Savani, R.C.; Salathe, M. Apical Oxidative Hyaluronan Degradation Stimulates Airway Ciliary Beating via RHAMM and RON. Am. J. Respir. Cell Mol. Biol. 2007, 37, 160–168. [Google Scholar] [CrossRef] [Green Version]
- Orikawa, H.; Kawaguchi, M.; Baba, T.; Yorita, K.; Sakoda, S.; Kataoka, H. Activation of macrophage-stimulating protein by human airway trypsin-like protease. FEBS Lett. 2012, 586, 217–221. [Google Scholar] [CrossRef] [Green Version]
- Becker, K.L.; Arts, P.; Jaeger, M.; Plantinga, T.S.; Gilissen, C.; van Laarhoven, A.; van Ingen, J.; Veltman, J.A.; Joosten, L.A.; Hoischen, A.; et al. MST1R mutation as a genetic cause of Lady Windermere syndrome. Eur. Respir. J. 2017, 49, 1601478. [Google Scholar] [CrossRef] [Green Version]
- Takano, Y.; Sakamoto, O.; Suga, M.; Suda, T.; Ando, M. Elevated levels of macrophage-stimulating protein in induced sputum of patients with bronchiectasis. Respir. Med. 2000, 94, 784–790. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gray, J.K.; Paluch, A.M.; Stuart, W.D.; Waltz, S.E. Ron receptor overexpression in the murine prostate induces prostate intraepithelial neoplasia. Cancer Lett. 2012, 314, 92–101. [Google Scholar] [CrossRef] [Green Version]
- Vasiliauskas, J.; Nashu, M.A.; Pathrose, P.; Starnes, S.L.; Waltz, S.E. Hepatocyte growth factor-like protein is required for prostate tumor growth in the TRAMP mouse model. Oncotarget 2014, 5, 5547–5558. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gurusamy, D.; Gray, J.K.; Pathrose, P.; Kulkarni, R.M.; Finkleman, F.D.; Waltz, S.E. Myeloid-Specific Expression of Ron Receptor Kinase Promotes Prostate Tumor Growth. Cancer Res 2013, 73, 1752–1763. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sullivan, C.; Brown, N.E.; Vasiliauskas, J.; Pathrose, P.; Starnes, S.L.; Waltz, S.E. Prostate Epithelial RON Signaling Promotes M2 Macrophage Activation to Drive Prostate Tumor Growth and Progression. Mol. Cancer Res. 2020, 18, 1244–1254. [Google Scholar] [CrossRef]
- Brown, N.E.; Jones, A.; Hunt, B.G.; Waltz, S.E. Prostate tumor RON receptor signaling mediates macrophage recruitment to drive androgen deprivation therapy resistance through Gas6-mediated Axl and RON signaling. Prostate 2022, 82, 1422–1437. [Google Scholar] [CrossRef]
- Peace, B.E.; Toney-Earley, K.; Collins, M.H.; Waltz, S.E. Ron Receptor Signaling Augments Mammary Tumor Formation and Metastasis in a Murine Model of Breast Cancer. Cancer Res 2005, 65, 1285–1293. [Google Scholar] [CrossRef] [Green Version]
- Zinser, G.M.; Leonis, M.A.; Toney, K.; Pathrose, P.; Thobe, M.; Kader, S.A.; Peace, B.E.; Beauman, S.R.; Collins, M.H.; Waltz, S.E. Mammary-Specific Ron Receptor Overexpression Induces Highly Metastatic Mammary Tumors Associated with β-Catenin Activation. Cancer Res 2006, 66, 11967–11974. [Google Scholar] [CrossRef] [Green Version]
- Wagh, P.K.; Zinser, G.M.; Gray, J.K.; Shrestha, A.; Waltz, S.E. Conditional deletion of β-catenin in mammary epithelial cells of Ron receptor, Mst1r, overexpressing mice alters mammary tumorigenesis. Endocrinology 2012, 153, 2735–2746. [Google Scholar] [CrossRef] [Green Version]
- Johnson, A.L.; Zinser, G.M.; Waltz, S.E. Vitamin D3-dependent VDR signaling delays ron-mediated breast tumorigenesis through suppression of β-catenin activity. Oncotarget 2015, 6, 16304–16320. [Google Scholar] [CrossRef] [Green Version]
- McClaine, R.J.; Marshal, A.M.; Wagh, P.K.; Waltz, S.E. Ron Receptor Tyrosine Kinase Activation Confers Resistance to Tamoxifen in Breast Cancer Cell Lines. Neoplasia 2010, 12, 650–658. [Google Scholar] [CrossRef] [Green Version]
- Marshall, A.M.; McClaine, R.J.; Gurusamy, D.; Gray, J.K.; Lewnard, K.E.; Khan, S.A.; Waltz, S.E. Estrogen receptor α deletion enhances the metastatic phenotype of Ron overexpressing mammary tumors in mice. Mol. Cancer 2012, 11, 2. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Dustin, D.; Gu, G.; Beyer, A.R.; Herzog, S.K.; Edwards, D.G.; Lin, H.; Gonzalez, T.L.; Grimm, S.L.; Coarfa, C.; Chan, D.W.; et al. RON signalling promotes therapeutic resistance in ESR1 mutant breast cancer. Br. J. Cancer 2021, 124, 191–206. [Google Scholar] [CrossRef] [PubMed]
- Ruiz-Torres, S.J.; Benight, N.M.; Karns, R.A.; Lower, E.E.; Guan, J.-L.; Waltz, S.E. HGFL-mediated RON signaling supports breast cancer stem cell phenotypes via activation of non-canonical β-catenin signaling. Oncotarget 2017, 8, 58918–58933. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ruiz-Torres, S.J.; Bourn, J.R.; Benight, N.M.; Hunt, B.G.; Lester, C.; Waltz, S.E. Macrophage-mediated RON signaling supports breast cancer growth and progression through modulation of IL-35. Oncogene 2022, 41, 321–333. [Google Scholar] [CrossRef] [PubMed]
- Bourn, J.R.; Ruiz-Torres, S.J.; Hunt, B.G.; Benight, N.M.; Waltz, S.E. Tumor cell intrinsic RON signaling suppresses innate immune responses in breast cancer through inhibition of IRAK4 signaling. Cancer Lett. 2021, 503, 75–90. [Google Scholar] [CrossRef]
- Eyob, H.; Ekiz, H.A.; DeRose, Y.S.; Waltz, S.E.; Williams, M.A.; Welm, A.L. Inhibition of Ron kinase blocks conversion of micrometastases to overt metastases by boosting anti-tumor immunity. Cancer Discov. 2013, 3, 751–760. [Google Scholar] [CrossRef] [Green Version]
- Zhu, C.; Wei, Y.; Wei, X. AXL receptor tyrosine kinase as a promising anti-cancer approach: Functions, molecular mechanisms and clinical applications. Mol. Cancer 2019, 18, 153. [Google Scholar] [CrossRef] [Green Version]
- Laurance, S.; Lemarié, C.A.; Blostein, M.D. Growth Arrest-Specific Gene 6 (gas6) and Vascular Hemostasis. Adv. Nutr. Int. Rev. J. 2012, 3, 196–203. [Google Scholar] [CrossRef] [Green Version]
- Sasaki, T.; Knyazev, P.G.; Clout, N.J.; Cheburkin, Y.; Göhring, W.; Ullrich, A.; Timpl, R.; Hohenester, E. Structural basis for Gas6–Axl signalling. EMBO J. 2006, 25, 80–87. [Google Scholar] [CrossRef] [Green Version]
- Cazes, A.; Childers, B.G.; Esparza, E.; Lowy, A.M. The MST1R/RON Tyrosine Kinase in Cancer: Oncogenic Functions and Therapeutic Strategies. Cancers 2022, 14, 2037. [Google Scholar] [CrossRef] [PubMed]
- Schroeder, G.M.; An, Y.; Cai, Z.W.; Chen, X.T.; Clark, C.; Cornelius, L.A.; Dai, J.; Gullo-Brown, J.; Gupta, A.; Henley, B.; et al. Discovery of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a selective and orally efficacious inhibitor of the Met kinase superfamily. J. Med. Chem. 2009, 52, 1251–1254. [Google Scholar] [CrossRef] [PubMed]
- Brown, N.E.; Paluch, A.M.; Nashu, M.A.; Komurov, K.; Waltz, S.E. Tumor Cell Autonomous RON Receptor Expression Promotes Prostate Cancer Growth Under Conditions of Androgen Deprivation. Neoplasia 2018, 20, 917–929. [Google Scholar] [CrossRef]
- Andrade, K.; Fornetti, J.; Zhao, L.; Miller, S.C.; Randall, R.L.; Anderson, N.; Waltz, S.E.; McHale, M.; Welm, A.L. RON kinase: A target for treatment of cancer-induced bone destruction and osteoporosis. Sci. Transl. Med. 2017, 9, eaai9338. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Christensen, J.G.; Schreck, R.; Burrows, J.; Kuruganti, P.; Chan, E.; Le, P.; Chen, J.; Wang, X.; Ruslim, L.; Blake, R.; et al. A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo. Cancer Res 2003, 63, 7345–7355. [Google Scholar] [PubMed]
- Prabhash, K.; Noronha, V.; Joshi, A.; Desai, S.; Sahu, A. Crizotinib: A comprehensive review. South Asian J. Cancer 2013, 2, 91–97. [Google Scholar] [CrossRef] [PubMed]
- Qian, F.; Engst, S.; Yamaguchi, K.; Yu, P.; Won, K.-A.; Mock, L.; Lou, T.; Tan, J.; Li, C.; Tam, D.; et al. Inhibition of Tumor Cell Growth, Invasion, and Metastasis by EXEL-2880 (XL880, GSK1363089), a Novel Inhibitor of HGF and VEGF Receptor Tyrosine Kinases. Cancer Res 2009, 69, 8009–8016. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Faham, N.; Zhao, L.; Welm, A.L. mTORC1 is a key mediator of RON-dependent breast cancer metastasis with therapeutic potential. NPJ Breast Cancer 2018, 4, 36. [Google Scholar] [CrossRef] [Green Version]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Hunt, B.G.; Fox, L.H.; Davis, J.C.; Jones, A.; Lu, Z.; Waltz, S.E. An Introduction and Overview of RON Receptor Tyrosine Kinase Signaling. Genes 2023, 14, 517. https://doi.org/10.3390/genes14020517
Hunt BG, Fox LH, Davis JC, Jones A, Lu Z, Waltz SE. An Introduction and Overview of RON Receptor Tyrosine Kinase Signaling. Genes. 2023; 14(2):517. https://doi.org/10.3390/genes14020517
Chicago/Turabian StyleHunt, Brian G., Levi H. Fox, James C. Davis, Angelle Jones, Zhixin Lu, and Susan E. Waltz. 2023. "An Introduction and Overview of RON Receptor Tyrosine Kinase Signaling" Genes 14, no. 2: 517. https://doi.org/10.3390/genes14020517